EP Patent

EP2099456A2 — N-oxides of 4,5-epoxy-morphinanium analogs

Assigned to Progenics Pharmaceuticals Inc · Expires 2009-09-16 · 17y expired

What this patent protects

Novel N-oxides of 4,5-epoxy-morphinanium analogs are disclosed. Pharmaceutical compositions containing the N-oxides of 4,5-epoxy-morphinanium analogs and methods of their pharmaceutical uses are also disclosed. The compounds disclosed are useful, inter alia, as modulators of opio…

USPTO Abstract

Novel N-oxides of 4,5-epoxy-morphinanium analogs are disclosed. Pharmaceutical compositions containing the N-oxides of 4,5-epoxy-morphinanium analogs and methods of their pharmaceutical uses are also disclosed. The compounds disclosed are useful, inter alia, as modulators of opioid receptors.

Drugs covered by this patent

Patent Metadata

Patent number
EP2099456A2
Jurisdiction
EP
Classification
—
Expires
2009-09-16
Drug substance claim
No
Drug product claim
No
Assignee
Progenics Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.